NCCN makes changes to its guidelines for treating fever and neutropenia.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005334:Fever / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D009503:Neutropenia / Q000139:chemically induced / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D014481:United States
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents